According to a new report by Polaris Market Research, the global Specialty Generic Drugs market was valued at USD 89.55 billion in 2025 and is projected to reach USD 202.66 billion by 2034, expanding at a CAGR of 9.5% over the forecast period. Growth is underpinned by the rising prevalence of chronic and rare diseases, expanding regulatory support for biosimilars and complex generics,...